DERIVATE MIT 2,3-DIHYDRO-1H-INDEN- ODER 2,3-DIHYDROBENZOFURANTEIL ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON UND DIESE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
European patent · EP4041733 · In force
Register entry
- Publication number
- EP4041733
- Application number
- EP20887669
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 12, 2020
- Published
- Aug 17, 2022
- Granted
- May 8, 2024
- Protection ends at the latest
- Nov 11, 2040
- Next annual fee due
- Nov 30, 2026
- IPC classes
- C07D 453/02 (2006.01)A61P 25/16 (2006.01)A61K 31/439 (2006.01)
- Priority
- KR 20190146679 15.11.2019
- PCT application
- PCT/KR2020/015864 12.11.2020
- PCT publication
- WO2021/096238 20.05.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 1, 2025
Change
Published in Swissreg on 01.12.2025
- Mar 19, 2025
Change
Published in Swissreg on 19.03.2025
- Dec 1, 2024
Change
Published in Swissreg on 01.12.2024
- May 31, 2024
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach, 8027 Zürich
Published in Swissreg on 31.05.2024
- May 8, 2024
Granted
Published in Swissreg on 08.05.2024
Parties
Holder
Inventor
Yongin-si, Gyeonggi-do 17097, KR
Yongin-si, Gyeonggi-do 17065, KR
Yongin-si, Gyeonggi-do 17080, KR
Yongin-si, Gyeonggi-do 17084, KR
Yongin-si, Gyeonggi-do 17086, KR
Osan-si, Gyeonggi-do 18107, KR
Suwon-si, Gyeonggi-do 16684, KR
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.